Norepinephrine Releasing Agent Drug Class List
✉ Email this page to a colleague
Drugs in Drug Class: Norepinephrine Releasing Agent
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dr Reddys Labs Sa | REZIPRES | ephedrine hydrochloride | SOLUTION;INTRAVENOUS | 213536-001 | Jun 14, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Dr Reddys Labs Sa | REZIPRES | ephedrine hydrochloride | SOLUTION;INTRAVENOUS | 213536-002 | Jun 14, 2021 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Dr Reddys Labs Sa | REZIPRES | ephedrine hydrochloride | SOLUTION;INTRAVENOUS | 213536-003 | Jun 14, 2021 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Dr Reddys Labs Sa | REZIPRES | ephedrine hydrochloride | SOLUTION;INTRAVENOUS | 213536-004 | Dec 7, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Operand Pharms | EPHEDRINE SULFATE | ephedrine sulfate | SOLUTION;INTRAVENOUS | 213994-002 | Apr 22, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
